Jeanne M. Carroll
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Jeanne M. Carroll has a total of 86 co-authors. Here are the top co-authors by number of shared publications:
- Albert Oriol
CHCIO, Rady Childrens
1 shared publication - Alicia G. Sykes
Rady Children's Hospital San Diego, San Diego, CA, United States
1 shared publication Alison Frith
Clinithink Ltd., London N1 6DR, UK
1 shared publication- Amber Hildreth
Division of Gastroenterology, Hepatology, and Nutrition; Department of Pediatrics University of California San Diego, Rady Children's Hospital San Diego California USA
1 shared publication Amie Wong
Rady Children's Hospital, San Diego, CA, USA
1 shared publicationAmy Kimball
Department of Pediatrics, University of California, San Diego School of Medicine, San Diego, CA, USA
1 shared publication
Latest Publications
- Open Access
- 29 April 2026
- Published by Springer Nature in Journal of Perinatology
Tiny doses, big impact: Optimizing sedation weaning to reduce opioid use in a Level IV NICU
Objective: Infants in the NICU often require prolonged sedation, increasing risk for iatrogenic withdrawal. We aimed to reduce mean opioid exposure by 20% (26 to 21 days) by May 2023, with sustained improvement through May 2024. Study design: A multidisciplinary team used the Model for Improvement with iterative Plan-Do-Study-Act cycles and EHR tools to implement a standardized sedation-weaning guideline. Applicable outcome, process, and balancing measures were analyzed using statistical process control charts. Results: Among patients receiving >4 days of opioids, mean exposure decreased from 26 to 17 days, length of stay from 70 to 50 days; and overall dexmedetomidine exposure from 18 to 12 days. Adherence to individualized weaning plans improved and feedback indicated effective withdrawal management. Conclusions: Standardized weaning reduced opioid exposure, LOS, and sedative use, enhancing safety, care quality, and NICU capacity.
- 29 April 2026
- Published by Springer Nature in Journal of Perinatology
Open AccessTiny doses, big impact: Optimizing sedation weaning to reduce opioid use in a Level IV NICU
Objective: Infants in the NICU often require prolonged sedation, increasing risk for iatrogenic withdrawal. We aimed to reduce mean opioid exposure by 20% (26 to 21 days) by May 2023, with sustained improvement through May 2024. Study design: A multidisciplinary team used the Model for Improvement with iterative Plan-Do-Study-Act cycles and EHR tools to implement a standardized sedation-weaning guideline. Applicable outcome, process, and balancing measures were analyzed using statistical process control charts. Results: Among patients receiving >4 days of opioids, mean exposure decreased from 26 to 17 days, length of stay from 70 to 50 days; and overall dexmedetomidine exposure from 18 to 12 days. Adherence to individualized weaning plans improved and feedback indicated effective withdrawal management. Conclusions: Standardized weaning reduced opioid exposure, LOS, and sedative use, enhancing safety, care quality, and NICU capacity.
- 1 June 2021
- Published by Elsevier in Journal of Pediatric Surgery
- Vol. 56 (6) , 1130-1134
Identifying risk factors for enteral access procedures in neonates with congenital diaphragmatic hernia: A novel risk-assessment score
- 1 June 2021
- Published by Elsevier in Journal of Pediatric Surgery
- Vol. 56 (6) , 1130-1134
Identifying risk factors for enteral access procedures in neonates with congenital diaphragmatic hernia: A novel risk-assessment score
- 24 April 2019
- Published by American Association for the Advancement of Science (AAAS) in Science Translational Medicine
- Vol. 11 (489)
Diagnosis of genetic diseases in seriously ill children by rapid whole-genome sequencing and automated phenotyping and interpretation
Automated phenotyping and interpretation of rapid whole-genome sequencing improve time to diagnosis of genetic diseases in hospitalized children.
- 24 April 2019
- Published by American Association for the Advancement of Science (AAAS) in Science Translational Medicine
- Vol. 11 (489)
Diagnosis of genetic diseases in seriously ill children by rapid whole-genome sequencing and automated phenotyping and interpretation
Automated phenotyping and interpretation of rapid whole-genome sequencing improve time to diagnosis of genetic diseases in hospitalized children.
- 16 May 2014
- Published by Wiley in Current Protocols in Stem Cell Biology
- Vol. 29 (1) , 1C.16.1-1C.16.13
Generation, Expansion, and Differentiation of Human Induced Pluripotent Stem Cells (hiPSCs) Derived From the Umbilical Cords of Newborns
The umbilical cord is tissue that is normally discarded after the delivery of the infant, but it has been shown to be a rich source of stem cells from the cord blood, Wharton's jelly, and umbilical endothelial cells. Patient‐specific human induced pluripotent stem cells (hiPSCs) reprogrammed from patient specific human umbilical vein endothelial cells in the neonatal intensive care unit (NICU) population (specifically, premature neonates) have not been shown in the literature. This unit describes a protocol for the generation and expansion of hiPSCs originating from umbilical cords collected from patients in the NICU. Curr. Protoc. Stem Cell Biol. 29:1C.16.1‐1C.16.13. © 2014 by John Wiley & Sons, Inc. Keywords: umbilical cord; HUVEC; reprogramming; iPS
- 16 May 2014
- Published by Wiley in Current Protocols in Stem Cell Biology
- Vol. 29 (1) , 1C.16.1-1C.16.13
Generation, Expansion, and Differentiation of Human Induced Pluripotent Stem Cells (hiPSCs) Derived From the Umbilical Cords of Newborns
The umbilical cord is tissue that is normally discarded after the delivery of the infant, but it has been shown to be a rich source of stem cells from the cord blood, Wharton's jelly, and umbilical endothelial cells. Patient‐specific human induced pluripotent stem cells (hiPSCs) reprogrammed from patient specific human umbilical vein endothelial cells in the neonatal intensive care unit (NICU) population (specifically, premature neonates) have not been shown in the literature. This unit describes a protocol for the generation and expansion of hiPSCs originating from umbilical cords collected from patients in the NICU. Curr. Protoc. Stem Cell Biol. 29:1C.16.1‐1C.16.13. © 2014 by John Wiley & Sons, Inc. Keywords: umbilical cord; HUVEC; reprogramming; iPS